|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murata Y, Yasuo T, Yoshida R, Obata K,
Yanagawa Y, Margolskee RF and Ninomiya Y: Action potential-enhanced
ATP release from taste cells through hemichannels. J Neurophysiol.
104:896–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pellegatti P, Raffaghello L, Bianchi G,
Piccardi F, Pistoia V and Di Virgilio F: Increased level of
extracellular ATP at tumor sites: In vivo imaging with plasma
membrane luciferase. PLoS One. 3:e25992008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Arcuino G, Takano T, Lin J, Peng
WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, et al: P2×7 receptor
inhibition improves recovery after spinal cord injury. Nat Med.
10:821–827. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raffaghello L, Chiozzi P, Falzoni S, Di
Virgilio F and Pistoia V: The P2×7 receptor sustains the growth of
human neuroblastoma cells through a substance P-dependent
mechanism. Cancer Res. 66:907–914. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di Virgilio F: Purines, purinergic
receptors, and cancer. Cancer Res. 72:5441–5447. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stagg J and Smyth MJ: Extracellular
adenosine triphosphate and adenosine in cancer. Oncogene.
29:5346–5358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L, He HY, Li HM, Zheng J, Heng WJ,
You JF and Fang WG: ERK1/2 and p38 pathways are required for P2Y
receptor-mediated prostate cancer invasion. Cancer Lett.
215:239–247. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Gong LH, Zhang HQ, Du Q, You JF,
Tian XX and Fang WG: Extracellular ATP enhances in vitro invasion
of prostate cancer cells by activating Rho GTPase and upregulating
MMPs expression. Cancer Lett. 293:189–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li WH, Qiu Y, Zhang HQ, Liu Y, You JF,
Tian XX and Fang WG: P2Y2 receptor promotes cell invasion and
metastasis in prostate cancer cells. Br J Cancer. 109:1666–1675.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J, Liao Z, Camden J, Griffin KD,
Garrad RC, Santiago-Pérez LI, González FA, Seye CI, Weisman GA and
Erb L: Src homology 3 binding sites in the P2Y2 nucleotide receptor
interact with Src and regulate activities of Src, proline-rich
tyrosine kinase 2, and growth factor receptors. J Biol Chem.
279:8212–8218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tu MT, Luo SF, Wang CC, Chien CS, Chiu CT,
Lin CC and Yang CM: P2Y2 receptor-mediated proliferation of C6
glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br J
Pharmacol. 129:1481–1489. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muscella A, Elia MG, Greco S, Storelli C
and Marsigliante S: Activation of P2Y2 receptor induces c-FOS
protein through a pathway involving mitogen-activated protein
kinases and phosphoinositide 3-kinases in HeLa cells. J Cell
Physiol. 195:234–240. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nylund G, Hultman L, Nordgren S and Delbro
DS: P2Y2- and P2Y4 purinergic receptors are over-expressed in human
colon cancer. Auton Autacoid Pharmacol. 27:79–84. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Künzli BM, Bernlochner MI, Rath S, Käser
S, Csizmadia E, Enjyoji K, Cowan P, d'Apice A, Dwyer K, Rosenberg
R, et al: Impact of CD39 and purinergic signalling on the growth
and metastasis of colorectal cancer. Purinergic Signal. 7:231–241.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG), . Effects of chemotherapy and
hormonal therapy for early breast cancer on recurrence and 15-year
survival: An overview of the randomised trials. Lancet.
365:1687–1717. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blamey RW, Ellis IO, Pinder SE, Lee AH,
Macmillan RD, Morgan DA, Robertson JF, Mitchell MJ, Ball GR,
Haybittle JL, et al: Survival of invasive breast cancer according
to the Nottingham Prognostic Index in cases diagnosed in 1990–1999.
Eur J Cancer. 43:1548–1555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Albini A, Iwamoto Y, Kleinman HK, Martin
GR, Aaronson SA, Kozlowski JM and McEwan RN: A rapid in vitro assay
for quantitating the invasive potential of tumor cells. Cancer Res.
47:3239–3245. 1987.PubMed/NCBI
|
|
21
|
Matos LL, Stabenow E, Tavares MR, Ferraz
AR, Capelozzi VL and Pinhal MA: Immunohistochemistry quantification
by a digital computer-assisted method compared to semiquantitative
analysis. Clinics. 61:417–424. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schafer R, Sedehizade F, Welte T and
Reiser G: ATP- and UTP-activated P2Y receptors differently regulate
proliferation of human lung epithelial tumor cells. Am J Physiol
Lung Cell Mol Physiol. 285:L376–L385. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
White N, Ryten M, Clayton E, Butler P and
Burnstock G: P2Y purinergic receptors regulate the growth of human
melanomas. Cancer Lett. 224:81–91. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maaser K, Höpfner M, Kap H, Sutter AP,
Barthel B, von Lampe B, Zeitz M and Scherübl H: Extracellular
nucleotides inhibit growth of human oesophageal cancer cells via
P2Y2-receptors. Br J Cancer. 86:636–644. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Höpfner M, Maaser K, Barthel B, von Lampe
B, Hanski C, Riecken EO, Zeitz M and Scherübl H: Growth inhibition
and apoptosis induced by P2Y2 receptors in human colorectal
carcinoma cells: Involvement of intracellular calcium and cyclic
adenosine monophosphate. Int J Colorectal Dis. 16:154–166. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu Y, Li WH, Zhang HQ, Liu Y, Tian XX and
Fang WG: P2×7 mediates ATP-driven invasiveness in prostate cancer
cells. PLoS One. 9:e1143712014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang WG, Pirnia F, Bang YJ, Myers CE and
Trepel JB: P2-purinergic receptor agonists inhibit the growth of
androgen-independent prostate carcinoma cells. J Clin Invest.
89:191–196. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adinolfi E: New intriguing roles of ATP
and its receptors in promoting tumor metastasis: Presented by Maria
P. Abbracchio. Purinergic Signal. 9:487–490. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schumacher D, Strilic B, Sivaraj KK,
Wettschureck N and Offermanns S: Platelet-derived nucleotides
promote tumor-cell transendothelial migration and metastasis via
P2Y2 receptor. Cancer Cell. 24:130–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jelassi B, Anchelin M, Chamouton J,
Cayuela ML, Clarysse L, Li J, Goré J, Jiang LH and Roger S:
Anthraquinone emodin inhibits human cancer cell invasiveness by
antagonizing P2×7 receptors. Carcinogenesis. 34:1487–1496. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chadet S, Jelassi B, Wannous R, Angoulvant
D, Chevalier S, Besson P and Roger S: The activation of P2Y2
receptors increases MCF-7 breast cancer cells migration through the
MEK-ERK1/2 signalling pathway. Carcinogenesis. 35:1238–1247. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sarrió D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Trimboli AJ, Fukino K, de Bruin A, Wei G,
Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, et al:
Direct evidence for epithelial-mesenchymal transitions in breast
cancer. Cancer Res. 68:937–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Davis FM, Kenny PA, Soo ET, van Denderen
BJ, Thompson EW, Cabot PJ, Parat MO, Roberts-Thomson SJ and
Monteith GR: Remodeling of purinergic receptor-mediated
Ca2+ signaling as a consequence of EGF-induced
epithelial-mesenchymal transition in breast cancer cells. PLoS One.
6:e234642011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bilbao P Scodelaro, Boland R, de Boland A
Russo and Santillán G: ATP modulation of mitogen activated protein
kinases and intracellular Ca2+ in breast cancer (MCF-7)
cells. Arch Biochem Biophys. 466:15–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blanco MJ, Moreno-Bueno G, Sarrio D,
Locascio A, Cano A, Palacios J and Nieto MA: Correlation of Snail
expression with histological grade and lymph node status in breast
carcinomas. Oncogene. 21:3241–3246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wolff CI, Bundey RA and Insel PA:
Involvement of P2Y receptors in TGFβ-induced EMT of MDCK cells.
FASEB J. 22:942–945. 2008.
|
